Lb Pharmaceuticals (LBRX) EBITDA (2024 - 2026)
Lb Pharmaceuticals' (LBRX) quarterly EBITDA came in at $5.4 million in Q1 2026, up 201.76% year-on-year from $1.8 million in Q1 2025, and up 147.53% quarter-over-quarter from -$11.3 million in Q4 2025.
Lb Pharmaceuticals (LBRX) EBITDA (2024 - 2026) Analysis & Trends
Lb Pharmaceuticals' EBITDA history runs 3 years deep, the most recent figure standing at $5.4 million for Q1 2026.
- On a quarterly basis, EBITDA rose 201.76% year-over-year to $5.4 million in Q1 2026; TTM through Mar 2026 was -$14.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $4.5 million, up 111.25% from the prior year.
- EBITDA rose to $5.4 million in Q1 2026 per LBRX's latest filing, from -$11.3 million in the prior quarter.
- Across five years, EBITDA topped out at $5.4 million in Q1 2026 and bottomed at -$14.2 million in Q3 2024.
- The 3-year median for EBITDA is -$5.2 million (2024), against an average of -$5.6 million.
- Across the five-year window, EBITDA sank 122.66% in 2025 and surged 201.76% in 2026, its largest moves.
- Year by year, EBITDA stood at -$5.1 million in 2024, then sank by 122.66% to -$11.3 million in 2025, then soared by 147.53% to $5.4 million in 2026.
- Per Business Quant, the three latest LBRX EBITDA figures stand at $5.4 million (Q1 2026), -$11.3 million (Q4 2025), and -$2.9 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Lb Pharmaceuticals | 977.73 Mn | 977.73 Mn | - | 5.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.37 Mn |
| Dec 31, 2025 | -11.29 Mn |
| Sep 30, 2025 | -2.93 Mn |
| Mar 31, 2025 | -5.27 Mn |
| Dec 31, 2024 | -5.07 Mn |
| Sep 30, 2024 | -14.18 Mn |